Gene · 5352
Papers1,610
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,610
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cellular senescence throws new insights into patient classification and pharmacological interventions for clinical management of hepatocellular carcinoma. | World J Gastrointest Oncol | 2023 | 37746655 | PubTator, text mining | PubMed |
| Scoliosis in osteogenesis imperfecta: identifying the genetic and non-genetic factors affecting severity and progression from longitudinal data of 290 patients. | Orphanet J Rare Dis | 2023 | 37730650 | PubTator, text mining | PubMed |
| Construction of a ceRNA network to reveal a vascular invasion associated prognostic model in hepatocellular carcinoma. | Open Med (Wars) | 2023 | 37724126 | PubTator, text mining | PubMed |
| TGF-β signaling in health and disease. | Cell | 2023 | 37714133 | PubTator, text mining | PubMed |
| KLF5 Promotes Tumor Progression and Parp Inhibitor Resistance in Ovarian Cancer. | Adv Sci (Weinh) | 2023 | 37702443 | PubTator, text mining | PubMed |
| Prognostic and immune correlation analysis of mitochondrial autophagy and aging-related genes in lung adenocarcinoma. | J Cancer Res Clin Oncol | 2023 | 37698683 | PubTator, text mining | PubMed |
| Human Aldehyde Dehydrogenases: A Superfamily of Similar Yet Different Proteins Highly Related to Cancer. | Cancers (Basel) | 2023 | 37686694 | PubTator, text mining | PubMed |
| Differences in the Tumor Molecular and Microenvironmental Landscape between Early (Non-Metastatic) and De Novo Metastatic Primary Luminal Breast Tumors. | Cancers (Basel) | 2023 | 37686617 | PubTator, text mining | PubMed |
| Features of Congenital Arthrogryposis Due to Abnormalities in Collagen Homeostasis, a Scoping Review. | Int J Mol Sci | 2023 | 37686358 | PubTator, text mining | PubMed |
| N6-methyladenosine modification of PLOD2 causes spermatocyte damage in rats with varicocele. | Cell Mol Biol Lett | 2023 | 37670228 | PubTator, text mining | PubMed |
| Stromal cells in the tumor microenvironment: accomplices of tumor progression? | Cell Death Dis | 2023 | 37666813 | PubTator, text mining | PubMed |
| Breast stiffness, a risk factor for cancer and the role of radiology for diagnosis. | J Transl Med | 2023 | 37649088 | PubTator, text mining | PubMed |
| Oral fibroblasts rescue osteogenic differentiation of mesenchymal stem cells after exposure to Zoledronic acid in a paracrine effect. | Front Pharmacol | 2023 | 37637413 | PubTator, text mining | PubMed |
| Systematic establishment and verification of an epithelial-mesenchymal transition gene signature for predicting prognosis of oral squamous cell carcinoma. | Front Genet | 2023 | 37636263 | PubTator, text mining | PubMed |
| Molecular characteristics, clinical significance, and immune landscape of extracellular matrix remodeling-associated genes in colorectal cancer. | Front Oncol | 2023 | 37621680 | PubTator, text mining | PubMed |
| Can AI Mitigate Bias in Writing Letters of Recommendation? | JMIR Med Educ | 2023 | 37610808 | PubTator, text mining | PubMed |
| Minoxidil weakens newly synthesized collagen in fibrotic synoviocytes from osteoarthritis patients. | J Exp Orthop | 2023 | 37605092 | PubTator, text mining | PubMed |
| Clinical and molecular description of the first Italian cohort of 33 subjects with hypophosphatasia. | Front Endocrinol (Lausanne) | 2023 | 37600704 | PubTator, text mining | PubMed |
| Withdrawal: Hypoxia-inducible factor 1 (HIF-1) promotes extracellular matrix remodeling under hypoxic conditions by inducing P4HA1, P4HA2, and PLOD2 expression in fibroblasts. | J Biol Chem | 2023 | 37586148 | PubTator, text mining | PubMed |
| Canagliflozin mediates tumor suppression alone and in combination with radiotherapy in non-small cell lung cancer (NSCLC) through inhibition of HIF-1α. | Mol Oncol | 2023 | 37584455 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5352/papers?page=8